Haldol, Haldol Solutab (haloperidol) is a small molecule pharmaceutical. Haloperidol was first approved as Haldol on 1982-01-01. It is used to treat child behavior disorders, psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders, and substance withdrawal syndrome amongst others in the USA. The pharmaceutical is active against D(3) dopamine receptor, D(2) dopamine receptor, 5-hydroxytryptamine receptor 2A, and D(4) dopamine receptor. In addition, it is known to target histamine H1 receptor, 5-hydroxytryptamine receptor 7, 5-hydroxytryptamine receptor 1A, D(1A) dopamine receptor, potassium voltage-gated channel subfamily H member 1, 5-hydroxytryptamine receptor 1D, D(1B) dopamine receptor, 5-hydroxytryptamine receptor 2B, and G protein-activated inward rectifier potassium channel 2.
|Trade Name||Haldol, Haldol Solutab|
|Indication||child behavior disorders, psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders, substance withdrawal syndrome, tourette syndrome, vomiting|
|Drug Class||Antipsychotics (haloperidol type)|